Comparison of Angiomax Versus Heparin in Acute Coronary Syndromes (ACS)
- Conditions
- First Posted Date
- 2004-10-07
- Last Posted Date
- 2007-08-21
- Lead Sponsor
- The Medicines Company
- Target Recruit Count
- 13800
- Registration Number
- NCT00093158
- Locations
- 🇺🇸
Cardiovascular Research Foundation, New York, New York, United States
Bivalirudin in Patients With Acute Myocardial Infarction (AMI) Undergoing Primary PCI
- Conditions
- First Posted Date
- 2004-10-07
- Last Posted Date
- 2006-02-09
- Lead Sponsor
- The Medicines Company
- Target Recruit Count
- 300
- Registration Number
- NCT00093184
- Locations
- 🇺🇸
The Heart Care Research Foundation, Blue Island, Illinois, United States
Study of Clevidipine Assessing Its Postoperative Antihypertensive Effect in Cardiac Surgery (ESCAPE-2)
- First Posted Date
- 2004-10-07
- Last Posted Date
- 2014-05-08
- Lead Sponsor
- The Medicines Company
- Target Recruit Count
- 206
- Registration Number
- NCT00093262
- Locations
- 🇺🇸
Keck School of Medicine, University of Southern California, Los Angeles, California, United States
🇺🇸Emory Hospital, Atlanta, Georgia, United States
🇺🇸International Heart Institute, Missoula, Montana, United States
Study of Clevidipine Assessing Its Preoperative Antihypertensive Effect in Cardiac Surgery (ESCAPE-1)
- First Posted Date
- 2004-10-07
- Last Posted Date
- 2014-08-22
- Lead Sponsor
- The Medicines Company
- Target Recruit Count
- 105
- Registration Number
- NCT00093249
- Locations
- 🇺🇸
Cardio-Thoracic Surgeons, PC, Birmingham, Alabama, United States
🇺🇸St Vincent Medical Center, Los Angeles, California, United States
🇺🇸Memorial Herman Memorial City Hospital, Houston, Texas, United States
Comparing Angiomax to Heparin With Protamine in Patients Undergoing Cardiopulmonary Bypass (CPB)
- Conditions
- Interventions
- First Posted Date
- 2004-03-11
- Last Posted Date
- 2012-01-05
- Lead Sponsor
- The Medicines Company
- Target Recruit Count
- 150
- Registration Number
- NCT00079586
- Locations
- 🇺🇸
The Cleveland Clinic, Cleveland, Ohio, United States
Angiomax in Patients With HIT/HITTS Type II Undergoing CPB
- Conditions
- First Posted Date
- 2004-03-11
- Last Posted Date
- 2011-11-10
- Lead Sponsor
- The Medicines Company
- Target Recruit Count
- 125
- Registration Number
- NCT00079508
- Locations
- 🇺🇸
The Cleveland Clinic, Cleveland, Ohio, United States
Angiomax in Patients With HIT/HITTS Type II Undergoing Off-Pump Coronary Artery Bypass Grafting (CABG) (CHOOSE)
- Conditions
- First Posted Date
- 2003-11-27
- Last Posted Date
- 2018-11-30
- Lead Sponsor
- The Medicines Company
- Target Recruit Count
- 88
- Registration Number
- NCT00073580
- Locations
- 🇺🇸
The Cleveland Clinic, Cleveland, Ohio, United States
Comparing Angiomax to Heparin With Protamine Reversal in Patients OPCAB
- Conditions
- Interventions
- First Posted Date
- 2003-11-27
- Last Posted Date
- 2011-11-10
- Lead Sponsor
- The Medicines Company
- Target Recruit Count
- 150
- Registration Number
- NCT00073593
- Locations
- 🇺🇸
Cleveland Clinic Foundation, Cleveland, Ohio, United States
Anticoagulant Therapy With Bivalirudin in the Performance of Percutaneous Coronary Intervention in Patients With Heparin-Induced Thrombocytopenia (AT BAT, First Inning)
- Conditions
- First Posted Date
- 2002-08-16
- Last Posted Date
- 2011-09-16
- Lead Sponsor
- The Medicines Company
- Target Recruit Count
- 50
- Registration Number
- NCT00043940
- Locations
- 🇺🇸
Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, United States
Study Of Angiomax In Infants Under Six Months With Thrombosis
- Conditions
- First Posted Date
- 2002-08-08
- Last Posted Date
- 2006-02-01
- Lead Sponsor
- The Medicines Company
- Target Recruit Count
- 25
- Registration Number
- NCT00043277
- Locations
- 🇺🇸
Children's Hospital of Orange County, Orange, California, United States